Evidence mapPaperPMID 37446302Full record

ReviewInternational journal of molecular sciences2023

Multi-Modality Imaging of Atheromatous Plaques in Peripheral Arterial Disease: Integrating Molecular and Imaging Markers.

Xiaomeng Wang, Ying-Hwey Nai, Julian Gan, Cheryl Pei Ling Lian, Fraser Kirwan Ryan, Forest Su Lim Tan, Dexter Yak Seng Chan, Jun Jie Ng, Zhiwen Joseph Lo, Tze Tec Chong and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Xiaomeng WangCardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.ORCID 0000-0002-1733-4109
Ying-Hwey NaiClinical Imaging Research Centre, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.ORCID 0000-0002-6634-8785
Julian GanSiemens Healthineers, Singapore 348615, Singapore.
Cheryl Pei Ling LianHealth and Social Sciences Cluster, Singapore Institute of Technology, Singapore 138683, Singapore.ORCID 0000-0003-2528-7477
Fraser Kirwan RyanInfocomm Technology Cluster, Singapore Institute of Technology, Singapore 138683, Singapore.
Forest Su Lim TanInfocomm Technology Cluster, Singapore Institute of Technology, Singapore 138683, Singapore.
Dexter Yak Seng ChanDepartment of General Surgery, Khoo Teck Puat Hospital, Singapore 768828, Singapore.ORCID 0000-0002-4741-6754
Jun Jie NgDivision of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre, Singapore 119074, Singapore.
Zhiwen Joseph LoVascular Surgery Service, Department of Surgery, Woodlands Health, Singapore 258499, Singapore.ORCID 0000-0003-2289-5266
Tze Tec ChongDepartment of Vascular Surgery, Singapore General Hospital, Singapore 168752, Singapore.
Derek John HausenloyCardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.
National University of Singapore · SGSingapore Institute of Technology · SGKhoo Teck Puat Hospital · SGNanyang Technological University · SGSiemens (Singapore) · SGSingapore General Hospital · SG

Funding

European Cooperation in Science and Technology EU-CARDIOPROTECTION IG16225National Medical Research Council FLWSHP19nov-0015National Medical Research Council MOH-000764-00National Medical Research Council MOH-STaR21jun-0003National Medical Research Council NMRC CG21APR1006National Medical Research Council NMRC/CG21APRC006National Research Foundation NRF CRP25-2020RS-0001
6 · The paper itself

Abstract

Peripheral artery disease (PAD) is a common and debilitating condition characterized by the narrowing of the limb arteries, primarily due to atherosclerosis. Non-invasive multi-modality imaging approaches using computed tomography (CT), magnetic resonance imaging (MRI), and nuclear imaging have emerged as valuable tools for assessing PAD atheromatous plaques and vessel walls. This review provides an overview of these different imaging techniques, their advantages, limitations, and recent advancements. In addition, this review highlights the importance of molecular markers, including those related to inflammation, endothelial dysfunction, and oxidative stress, in PAD pathophysiology. The potential of integrating molecular and imaging markers for an improved understanding of PAD is also discussed. Despite the promise of this integrative approach, there remain several challenges, including technical limitations in imaging modalities and the need for novel molecular marker discovery and validation. Addressing these challenges and embracing future directions in the field will be essential for maximizing the potential of molecular and imaging markers for improving PAD patient outcomes.

Indexed as

AtherosclerosisPeripheral Arterial DiseasePlaque, AtheroscleroticHumansMagnetic Resonance ImagingMultimodal ImagingPositron-Emission TomographyTomography, X-Ray Computedcomputed tomography (CT)magnetic resonance imaging (MRI)molecular markersperipheral artery disease (PAD)plaque imagingpositron emission tomography (PET)single-photon emission computerized tomography (SPECT)vascular inflammation

Identifiers

PMID37446302
PMCPMC10342137
OpenAlexW4383346334

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.